(Q43852683)

27 November 2017

title

Antitumor activity of tiazofurin in human colon carcinoma HT-29 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1358409

17 September 2022

1 reference

W. Zhen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1358409

17 September 2022

H. N. Jayaram

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1358409

17 September 2022

G. Weber

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1358409

17 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1358409

17 September 2022

publication date

1 January 1992

1 reference

27 November 2017

1 reference

27 November 2017

volume

10

1 reference

27 November 2017

issue

6

1 reference

27 November 2017

page(s)

505-511

1 reference

2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07357909209024812

Tiazofurin: a new antitumor agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909209024812

Studies on the mechanism of action of 2-beta-D-ribofuranosylthiazole-4-carboxamide--V. Factors governing the response of murine tumors to tiazofurin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909209024812

Studies on the mechanism of action of 2-beta-D-ribofuranosylthiazole-4-carboxamide (NSC 286193)--II. Relationship between dose level and biochemical effects in P388 leukemia in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909209024812

Relationships between the cytotoxicity of tiazofurin and its metabolism by cultured human lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909209024812

Clinical and molecular impact of inhibition of IMP dehydrogenase activity by tiazofurin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909209024812

The conversion of 2-β-D-ribofuranosylthiazole-4-carboxamide to an analogue of NAD with potent IMP dehydrogenase-inhibitory properties

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909209024812

Studies on the mechanism of action of tiazofurin metabolism to an analog of NAD with potent IMP dehydrogenase-inhibitory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909209024812

Initial studies on the mechanism of action of a new oncolytic thiazole nucleoside, 2-beta-D-ribofuranosylthiazole-4-carboxamide (NSC 286193).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909209024812

Mechanism of resistance to the oncolytic C-nucleoside 2-beta-D-ribofuranosylthiazole-4-carboxamide (NSC-286193).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909209024812

Inhibition of inosinate dehydrogenase by metabolites of 2-beta-D-ribofuranosyl thiazole-4-carboxamide.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909209024812

Biochemical mechanisms of resistance to tiazofurin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909209024812

Mechanism of resistance to tiazofurin in hepatoma 3924A.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909209024812

Selective sensitivity to tiazofurin of human leukemic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909209024812

Determination of thiazole-4-carboxamide adenine dinucleotide (TAD) levels in mononuclear cells of leukemic patients treated with tiazofurin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909209024812

Phase I and pharmacokinetic study of tiazofurin (TCAR, NSC 286193) administered by continuous infusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909209024812

Enzymology of cancer cells (first of two parts).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909209024812

10.3109/07357909209024812

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference